Pharmafile Logo

Glaucoma in perspective

- PMLiVE

CDC says no to AZ’s intranasal flu vaccine FluMist

US government data reports “poor” efficacy for the injected vaccine alternative

Novartis Gehry Building

Heart failure drug Entresto ‘could save 28,000 lives a year’

New independent report looks set to boost sales of Novartis’ drug into blockbuster territory

- PMLiVE

Gyros Protein Technologies appoints chairman

Dr Frank Witney brings experience from Affymetrix and Dionex

- PMLiVE

Things can only get better

How can pharma get closer to its dream scenario where patients adhere to their medicines? The answer could lay in understanding behaviours, engaging HCPs and... making medicine fun

- PMLiVE

Lilly promotes Aarti Shah as chief information officer

She moves up from her role as a global brand development leader

- PMLiVE

Digitally yours: How to build effective relationships in virtual space

Can you imagine life without mobile and digital access? Certainly not. But is the healthcare sector making the most of the opportunities?

- PMLiVE

Diabetes UK uses Lego to address diabetes myths

Teams up with Brickabetes to document the highs and lows of living with diabetes

- PMLiVE

Online brain training game to be trialled for Parkinson’s disease

MyCognition's AquaSnap Optimize aims to tackle cognitive impairment

- PMLiVE

Merck starts pivotal trials of new antibiotic combination

Continues testing after positive phase II results for relebactam addition 

National Institute for Health and Care Excellence NICE logo

NICE backs five new drugs after discounts agreed

Includes Novartis’ previously rejected lung cancer and melanoma therapies Zykadia and Mekinist

- PMLiVE

X4 appoints John Celebi as COO

He joins from Igenica Biotherapeutics

- PMLiVE

Why train… millennials?

Do companies get a return on investment when they train millennials? 

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links